The loudness dependence of auditory evoked potentials and effects of psychopathology and psychopharmacotherapy in psychiatric inpatients

• Published in: Human psychopharmacology Vol. 27; no. 6; pp. 595 - 604
• Main Authors: Ostermann, Julia, Uhl, Idun, Köhler, Elke, Juckel, Georg, Norra, Christine
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.11.2012
• Subjects: Adult; affective disorder; Antidepressive Agents - adverse effects; Antidepressive Agents - therapeutic use; Biomarkers; Bipolar Disorder - drug therapy; Bipolar Disorder - physiopathology; Cross-Sectional Studies; depression; Depressive Disorder, Major - drug therapy; Depressive Disorder, Major - physiopathology; event-related potentials (ERP); Evoked Potentials, Auditory - drug effects; Female; Humans; Hypnotics and Sedatives - adverse effects; Hypnotics and Sedatives - therapeutic use; loudness dependence of auditory evoked potentials (LDAEP); Loudness Perception - drug effects; Male; Middle Aged; Neurotransmitter Uptake Inhibitors - adverse effects; Neurotransmitter Uptake Inhibitors - therapeutic use; Psychiatric Status Rating Scales; Psychotic Disorders - drug therapy; Psychotic Disorders - physiopathology; Psychotropic Drugs - adverse effects; Psychotropic Drugs - therapeutic use; Retrospective Studies; schizophrenia; Schizophrenia - drug therapy; Schizophrenia - physiopathology; serotonin; Severity of Illness Index
• ISSN: 0885-6222; 1099-1077; 1099-1077
• DOI: 10.1002/hup.2269

Objective Many studies have provided evidence for the loudness dependence of auditory evoked potentials (LDAEP) as a marker for central serotonergic activity but remained inconclusive for its suitability in clinical use. Methods A cross‐sectional sample of 162 psychiatric inpatients (major depression N = 86, bipolar disorder N = 12, schizophrenia N = 50, and schizoaffective disorder N = 14) and 40 healthy subjects was retrospectively examined for LDAEP and effects of psychopathology and psychopharmacology. Results The LDAEP was weaker in patients with affective disorders than in healthy subjects but did not differentiate between the total patient sample and healthy controls. LDAEP correlated significantly with dimensions of the Brief Symptom Inventory in the total patient sample (depression, paranoid ideation, psychoticism, Global Symptom Index, and Positive Symptom Distress Index), in patients with affective disorders (depression) and with schizophrenia spectrum disorders (depression, psychoticism, Global Symptom Index, and Positive Symptom Distress Index). Similar correlations were found in depressed patients with a single noradrenergic and specific serotonergic antidepressant or serotonin–norepinephrine reuptake inhibitor. There was a negative correlation between dosage of typical antipsychotics and LDAEP. Hypnotics generally led to a lower LDAEP. Conclusion The LDAEP in patients is related to severity of psychopathologic syndromes irrespective of diagnosis. Chronic psychopharmacologic treatment may also differentially modulate the LDAEP, but longitudinal studies are needed. Copyright © 2012 John Wiley & Sons, Ltd.